Neoplasms
Showing NaN - NaN of 48
Tumors Trial in Worldwide (Letetresgene autoleucel)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel
-
Pittsburgh, Pennsylvania
- +5 more
Aug 7, 2023
Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules
Recruiting
- Neoplasms
- +13 more
- HTL0039732 Capsules
- HTL0039732 Capsules and atezolizumab infusion
-
Cambridge, United Kingdom
- +4 more
Jul 5, 2023
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)
Recruiting
- Non-Small Cell Lung Cancer
- +14 more
-
Glendale, California
- +12 more
Feb 2, 2023
Tumors Trial in Spain, United Kingdom, United States (BI 1387446, BI 754091)
Active, not recruiting
- Neoplasms
- BI 1387446
- BI 754091
-
Chapel Hill, North Carolina
- +7 more
Jan 23, 2023
Tumors Trial in Belgium, Japan, United States (BI 907828, BI 754091, BI 754111)
Recruiting
- Neoplasms
- BI 907828
- +2 more
-
Santa Monica, California
- +16 more
Jan 23, 2023
Tumors Trial in Canada, United Kingdom, United States (BI 754091)
Active, not recruiting
- Neoplasms
- BI 754091
-
Sarasota, Florida
- +12 more
Jan 9, 2023
Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)
Active, not recruiting
- Neoplasms
- Carcinoma, Non-Small-Cell Lung
- BI 754111
- BI 754091
-
Miami, Florida
- +14 more
Jan 9, 2023
Tumors Trial in Worldwide (Dostarlimab)
Recruiting
- Neoplasms
- Dostarlimab
-
Birmingham, Alabama
- +105 more
Nov 17, 2022
Anticoagulation in Venous Thromboembolism and Cancer
Active, not recruiting
- Neoplasms
- Embolism
- Apixaban
- +5 more
-
London, United KingdomPfizer Investigational Site
Nov 17, 2022
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel (lete-cel, GSK3377794)
- +2 more
-
Duarte, California
- +36 more
Oct 28, 2022
Tumors Trial in Worldwide (Biopsy)
Completed
- Neoplasms
- Biopsy
-
San Francisco, California
- +10 more
Aug 10, 2022
Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)
Recruiting
- Neoplasms
- Gene-modified (GM) T cell therapy
-
Birmingham, Alabama
- +173 more
Aug 1, 2022
Information Needs Around Parenteral nUTrition in Cancer
Completed
- Cancer
- +6 more
- Non-interventional study
-
London, United Kingdom
- +3 more
Jul 14, 2022
Tumor Metastasis, Neoplastic Processes, Tumors Trial in Canada (SUPR, VMAT)
Recruiting
- Neoplasm Metastasis
- +3 more
- SUPR
- VMAT
-
Prince George, British Columbia, Canada
- +4 more
Apr 6, 2022
Tumors Trial in Worldwide (GSK adoptive cell therapy)
Recruiting
- Neoplasms
- GSK adoptive cell therapy
-
Duarte, California
- +37 more
Feb 1, 2022
Tumors Trial in Worldwide (Oral daily administration of BAL101553)
Recruiting
- Neoplasms
- Oral daily administration of BAL101553
-
Leuven, Belgium
- +12 more
Jan 19, 2022
iKnife REIMS Project
Recruiting
- Neoplasms
- Neoplasm Malignant
- Rapid Evaporative Ionisation Mass Spectrometry (REIMS)
-
London, United Kingdom
- +1 more
Sep 1, 2021